Pharmacogenomics Committee

The Pharmacogenomics Committee is a newly formed group in the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). This committee is part of the Biomarker Sciences Program, which supports the research activities of the Therapeutic Studies Program and Cancer Control and Outcomes Program.

This new committee is joining four other scientific groups, by specialty: the Data Science Committee, Developmental Therapeutics Committee, Imaging Diagnostics and Biomarker Committee, and the Laboratory Science and Pathology Committee. Together, researchers in this program:

  • Evaluate and integrate cross-cutting biologic science opportunities
  • Attract basic and translational science from member and external organizations
  • Foster translational and correlative science across the Group

The description of this committee is in development.


Bryan P. Schneider, MD

Indiana University/Melvin and Bren Simon Cancer Center

Pharmacogenomics CommitteePharmacogenomics Committee
ECOG-ACRIN Cancer Research Group